| HS Code | 984654 |
| Product Name | Aspirin+Dipyridamole 24h SR capsules Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable |
| Api Type | Combination pharmaceutical active ingredient |
| Active Ingredients | Aspirin and Dipyridamole |
| Combination Ratio | Aspirin 25 mg + Dipyridamole 200 mg extended-release |
| Aspirin Strength | 25 mg |
| Dipyridamole Strength | 200 mg |
| Dosage Form | 24-hour sustained-release capsule |
| Release Profile | Sustained release over 24 hours |
| Route Of Administration | Oral |
| Therapeutic Class | Antiplatelet combination |
| Mechanism Of Action | Aspirin inhibits cyclooxygenase; dipyridamole inhibits phosphodiesterase and adenosine uptake |
| Approved Indications | Secondary stroke prevention in patients with transient ischemic attack or ischemic stroke |
| Contraindications | Hypersensitivity to aspirin or dipyridamole; active peptic ulcer; bleeding disorders; severe renal or hepatic impairment; aspirin-induced asthma |
| Warnings | Risk of bleeding, gastrointestinal ulceration, bronchospasm, hypotension, and dizziness |
| Adverse Reactions | Headache, dizziness, nausea, diarrhea, abdominal pain, bleeding, rash |
| Drug Interactions | Anticoagulants, antiplatelets, NSAIDs, thrombolytics, methotrexate, probenecid, uricosurics |
| Storage Conditions | Store at 20-25°C (68-77°F); excursions permitted to 15-30°C |
| Shelf Life | 24 months from date of manufacture |
| Packaging | Aluminum foil blister packs or HDPE bottles |
| Grade | Pharma Grade |
| Aspirin Cas | 50-78-2 |
| Dipyridamole Cas | 58-32-2 |
| Aspirin Molecular Formula | C9H8O4 |
| Dipyridamole Molecular Formula | C24H40N8O4 |
| Aspirin Molecular Weight | 180.16 g/mol |
| Dipyridamole Molecular Weight | 504.63 g/mol |
| Appearance | White to off-white to yellow powder or granules |
| Solubility | Aspirin slightly soluble in water; dipyridamole practically insoluble in water |
| Assay | 95.0% to 105.0% of labeled amount |
| Impurity Limits | As per pharmacopoeial requirements |
| Particle Size | Typical 90% less than 500 microns |
| Pharmacopoeial Standard | USP/EP/BP/IP |
| Regulatory Status | Prescription only |
| Oral Suitability | Suitable for oral capsule administration |
| Tablet Suitability | May be formulated into tablets with appropriate excipients |
| Granule Suitability | May be formulated into granules with appropriate excipients |
As an accredited Aspirin+Dipyridamole 24h SR capsules Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Aspirin+Dipyridamole 24h SR capsules Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!